Belpointe Asset Management LLC Horizon Therapeutics Public LTD CO Transaction History

Belpointe Asset Management LLC

  • $1.49 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$107.32 - $113.5 $21,678 - $22,927
-202 Reduced 96.65%
7 $0
Q4 2022

Feb 08, 2023
BUY
$62.39 - $113.8 $13,039 - $23,784
209 New
209 $23,000
Q4 2021

Feb 15, 2022
SELL
$98.56 - $119.91 $696,227 - $847,044
-7,064 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$91.91 - $110.37 $649,252 - $779,653
7,064 New
7,064 $774,000

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Belpointe Asset Management LLC Portfolio

Follow Belpointe Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email